Log in
Enquire now
‌

US Patent 8741559 Cellular assay employing detectable protein

Patent 8741559 was granted and assigned to DiscoveRx on June, 2014 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Current Assignee
‌
DiscoveRx
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8741559
Patent Inventor Names
Warren G. Lewis0
Daniel Kelly Treiber0
Lisa M. Wodicka0
Date of Patent
June 3, 2014
Patent Application Number
13265806
Date Filed
April 23, 2010
Patent Citations Received
‌
US Patent 11697840 Method of detecting analyte in a sample with binding reagent, first detection reagent, and second detection reagent
0
Patent Primary Examiner
‌
Jacob Cheu
Patent abstract

Provided herein are assays useful, for example, for determining the activity of a protein involved in a cellular process. In some embodiments, the activity of the protein is assessed using a nucleic acid tag, and in particular, by detecting the presence of a nucleic acid tag. Such assays can be used, for example, to study the effects of test compounds as modulators, e.g., inhibitors, agonists and antagonists, of protein activity.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8741559 Cellular assay employing detectable protein

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.